Here, we monitor GALNT7 at both the gene and protein level in multiple independent patient cohorts (comprising >2000 patient samples) and establish upregulation of GALNT7 as a feature of prostate cancer. This evidence concerns the gene GALNT7 and prostate carcinoma.